Validation Trial of a Novel Marker of Delayed Chemotherapy-induced Emesis
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2016, Vol 5, Issue 4
Abstract
Post hoc analyses of study data suggested that the ratio of substance P to 5-HIAA/creatinine was a novel marker associated with risk of developing delayed chemotherapy-induced emesis. In order to verify this finding, a new clinical trial was conducted to prospectively evaluate the marker in patients receiving chemotherapy of high emetic risk level. Treatment in this study was restricted to two doxorubicin and cyclophosphamide-containing regimens. Prior to chemotherapy, blood and urine samples were collected. Serum substance P and urine 5-HIAA and creatinine (Cr) were measured to calculate patient-specific ratios. The attending oncologist had the option to follow current antiemetic guidelines or the investigators’ recommendation based on the subject’s pretreatment marker ratio.Delayed chemotherapy-induced emesis was the primary symptom monitored.Calculated ratios were ranked highest to lowest using the previously identified value of >70 as the cutoff. Of the 36 patients enrolled in the study, 11 had ratios associated with increased risk of delayed emesis. Mean pretreatment ratios for patients with (+) and without (-) emesis were 74.2 and 48.8, respectively. Although non-parametric analysis indicated the between-emesis group variance was not significantly different, p=0.154, a clear trend was observed with a higher percentage of subjects exhibiting delayed symptoms with ratios >70.
Authors and Affiliations
Gerald M Higa
Keywords
Related Articles
- EP ID EP198259
- DOI 10.19070/2167-9118-1600020
- Views 115
- Downloads 0
20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock
Patients with a variety of malignancies have a greater tendency to acquire infections than patients with non-malignant disorders. Sepsis and septic shock are common complications in patients with cancer. As the most comm...
The Influence of Lifestyle Risk Factors on the Occurrence of Gynecological Cancers: A Review of the Evidence and Opportunities for Prevention and Management
Over one million gynecologic cancers have been diagnosed in women worldwide. The five main types of gynecologic cancer are: uterine, ovarian, cervical, vulvar and vaginal. This review describes the current evidence regar...
Patient-Centered Outcomes Research In Advanced Stage Lung Cancer: Study Design and Population
Background: In 2013, researchers at the University of Nebraska Medical Center (UNMC) received funding from the Patient-Centered Outcomes Research Institute to establish a study that outlines treatment options for patient...
Work with Cancer in Japan
Work with Cancer in Japan
Stochastic Mathematical Models of Carcinogenesis
Geneticists and molecular biologists have demonstrated that carcinogenesis is a stochastic multi-stage process with each cancer tumor being derived from a single stem cell which has sustained a finite number of genetic a...